Tun daga 2020, COVID-19 ya yi tasiri sosai ga masana'antar IVD ta duniya. Tare da ƙara yawan kulawa da gwajin acid acid ta ƙasashe da yawa, kamfanonin IVD ba kawai sun haɓaka samfuran gano ƙwayoyin cuta na numfashi ba amma sun yi amfani da wannan fasaha don haɓakawa da aikace -aikacen wasu samfuran gano ƙwayoyin cuta.
TIANGEN, a matsayin babban kamfani a fagen tsarkakewar acid acid kuma sanannen sanannen mai samar da albarkatun ƙasa a cikin filin IVD, ya nuna kansa a China (Shanghai) Lafiyar Jama'a, Rigakafin Cututtuka da Nunin Kayayyakin Kayayyaki da Nunin shigo da kaya da fitarwa (Shanghai) Fair) 2021 tare da kunshin maganin cutar ta sa. A cikin baje kolin, TIANGEN ya zurfafa fahimta da haɗin gwiwa tare da abokan cinikin kamfanin IVD a gida da waje da haɓaka kamfanonin IVD don samun ci gaba cikin sauri a cikin lokacin annoba.
Tun daga 2020, TIANGEN ta ba da gwaje-gwaje sama da miliyan 20 na reagents na haɓakar nucleic acid, sama da miliyan 150 na albarkatun ƙasa da ɗaruruwan masu cire acid na atomatik don rigakafin, sarrafawa da gwajin COVID-19.
Yawancin sanannun masana'antun IVD a cikin gida da waje sun gane kayan aikin hakar ƙwayar cutar TIANGEN. A cikin WHO Gwajin Amfani da Gaggawa na cutar Coronavirus (COVID-19) Rahoton Jama'a na IVDs IVDs wanda aka saki a watan Yuni 2020, an jera kayan haɓakar haɓakar acid na TIANGEN a matsayin samfurin da aka ba da shawarar don haɓakar acid a cikin COVID-19. A cikin Jerin Shawarwarin Reagents Reagents a cikin COVID-19 wanda Asusun Duniya ya buga a cikin Janairu 2021, an jera samfuran TIANGEN a matsayin kayan albarkatun kamfanoni da yawa a gida da waje.
TIANGEN, sanye take da cikakkiyar cancantar fitarwa da tsarin kasuwanci, ya faɗaɗa kasuwancin duniya zuwa ƙasashe da yankuna sama da 40, gami da Japan, Singapore, Faransa, Argentina, Kenya, da dai sauransu A cikin ci gaban kasuwancin ketare, TIANGEN yana haɗin gwiwa tare da gida Kamfanoni don yin tattaki zuwa faɗin duniya tare kuma suna taka muhimmiyar rawa wajen haɓaka ci gaban kiwon lafiyar dukkan bil'adama.
TIANGEN yana da ƙwarewar fiye da shekaru goma a cikin hidimar kasuwancin IVD tare da yanayin haɗin gwiwa na musamman wanda ya dace da abokan cinikin. Za a kafa ƙungiyar sabis na ƙwararru ta hanyar haɗa shugabannin R&D, fasaha da aikin don ƙira da samar da tsare -tsaren haɗin gwiwa daban -daban bisa ga bukatun abokin ciniki. An tsara wannan ƙirar don taimakawa abokan ciniki yadda yakamata don magance matsalolin da aka fuskanta a cikin R&D da samarwa da samarwa abokan ciniki mafita na musamman wanda ya dace da ci gaban gaba.
A cikin baje kolin fasahar kere-kere na kasar Sin (Shanghai) na wannan shekara, TIANGEN ya gabatar ba kawai manyan abubuwan da ake fitar da sinadarin nucleic acid na atomatik da wurin aiki da bututun mai ba har ma da kayayyakin reagent da albarkatun kasa don gwajin SARS-COV2, wanda ya jawo hankalin kamfanonin IVD na cikin gida da na waje. a cikin Fair don sadarwa.
TIANGEN koyaushe yana ba da ingantattun kayan albarkatun ƙasa da mafita na musamman don masana'antun bincike na ƙwayoyin cuta, cibiyoyin bincike na likita, CDC da sauran rukunin aikace-aikacen kuma suna ba da hanyoyin bincike daban-daban na kwayoyin halittu don jami'o'i, cibiyoyin bincike da sauran cibiyoyin bincike na kimiyya.
A cikin bayan annoba, TIANGEN zai ba kamfanonin IVD ƙarin sabbin mafita don gwajin ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta da sauran hanyoyin gano ƙwayoyin ƙwayoyin cuta da aiki hannu da hannu tare da duk abokan haɗin gwiwa don taimakawa abokan haɓaka haɓaka gasa a kasuwannin duniya da haɗin gwiwa tare da maraba da ƙalubalen gaba. .
Lokacin aikawa: Mar-21-2021
